These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3038552)

  • 1. Blood donor selection can prevent cytomegalovirus infection after open heart surgery.
    Gjesdal K; Orstavik I; Fagerhol M; Endresen K; Reikvam A; Ulstrup JC; Sivertssen E
    Eur Heart J; 1987 Apr; 8(4):378-81. PubMed ID: 3038552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection.
    Beneke JS; Tegtmeier GE; Alter HJ; Luetkemeyer RB; Solomon R; Bayer WL
    J Infect Dis; 1984 Dec; 150(6):883-8. PubMed ID: 6094676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated cytomegalovirus infections.
    Adler SP
    Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a prescreening blood donor program for prevention of perinatal transfusion-acquired cytomegalovirus (CMV) infection.
    Bhumbra NA; Lewandowski P; Lau P; Sererat M; Satish M; Nankervis GA
    J Perinat Med; 1988; 16(2):127-31. PubMed ID: 2845045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
    Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
    Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for prevention of post-transfusion cytomegalovirus infection in patients undergoing cardiac surgery.
    van Aken WG
    Eur Heart J; 1987 Apr; 8(4):382-3. PubMed ID: 3038553
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
    Bowden RA; Sayers M; Flournoy N; Newton B; Banaji M; Thomas ED; Meyers JD
    N Engl J Med; 1986 Apr; 314(16):1006-10. PubMed ID: 3007984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells.
    Luban NL; Williams AE; MacDonald MG; Mikesell GT; Williams KM; Sacher RA
    Am J Dis Child; 1987 Apr; 141(4):416-9. PubMed ID: 3031977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
    Yeager AS; Grumet FC; Hafleigh EB; Arvin AM; Bradley JS; Prober CG
    J Pediatr; 1981 Feb; 98(2):281-7. PubMed ID: 6257877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.
    Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H
    Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-acquired cytomegalovirus infection in cardiac surgery patients.
    Preiksaitis JK; Grumet FC; Smith WK; Merigan TC
    J Med Virol; 1985 Mar; 15(3):283-90. PubMed ID: 2984327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukocyte depletion and infection by cytomegalovirus].
    Mazeron MC
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():31s-35s. PubMed ID: 10919221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted cytomegalovirus infections: significance and control.
    Tegtmeier GE
    Vox Sang; 1986; 51 Suppl 1():22-30. PubMed ID: 3017003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
    Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
    J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cytomegalovirus antibody negative patients undergoing heart transplantation.
    Freeman R; Gould FK; McMaster A
    J Clin Pathol; 1990 May; 43(5):373-6. PubMed ID: 2164531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological screening for the prevention of transfusion-acquired cytomegalovirus infection.
    Musiani M; Zerbini M; Carpi C; Plazzi M; Sermasi G; Belletti D; Sacchi R
    J Infect; 1984 Sep; 9(2):148-52. PubMed ID: 6094671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
    Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
    Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.